Docs / GAISSF™ / Sector guidance
GAISSF™ Pharmaceutical Sector Executive Primer
ID SEC-049A
Framework GAISSF™ Type Sector guidance
What it coversExecutive orientation to pharmaceutical implementation and assurance evidence.
Scope and limitsNo universal global regulatory classification or validation method for pharmaceutical AI is assumed. Model accuracy alone is not treated as evidence of clinical, safety, quality or regulatory fitness.
Revision history
| Date (as stated) | Event | What changed |
|---|---|---|
| 5 Oct 2026 | Document revision | Draft for Publication issued; external review openSource: GAISSF-SEC-049A_Pharmaceutical_Executive_Primer_v1.0.pdf |
Earlier editions
Superseded copies, kept for reference and citation checks. Use the current edition above for any new work. Dates and statuses are as printed in each copy. An edition marked “held” is not republished; its checksum lets you confirm whether a copy you hold is that edition.
| Edition (as printed) | Status (as printed) | File |
|---|---|---|
| Version 1.1 (date not printed) | Held, not republished | Executive primer (PDF). Not available from this site.SHA-256 c5d8ccde39bde6b7a193855d08315347480542ed00bc85d15c555eae7d4e59f7 |
More from GAISSF™
| SEC-047 | GAISSF™ Telecommunications Sector Implementation Guide |
| NOR-001 | GAISSF™ Framework Standard |
| NOR-002 | GAISSF™ Executive Summary |
| NOR-003 | GAISSF™ Quick Start Guide |
Cite this document
ODA3 Institute. GAISSF™ Pharmaceutical Sector Executive Primer (SEC-049A), v1.0. 5 Oct 2026. docs.oda3.org/documents/sec-049a/
ODA3 Institute. GAISSF™ Pharmaceutical Sector Executive Primer (SEC-049A), v1.0. 5 Oct 2026. docs.oda3.org/documents/sec-049a/